This presentation offers an educational overview of autoimmune central nervous system (CNS) disorders, evaluations (including antibody testing), and treatments.
This week’s case study reviews a uterine leiomyomata, which was removed from a 27-year-old woman who presented for a myomectomy due to abnormal uterine bleeding. Can you make the diagnosis?
The Mayo Clinic School of Health Sciences 10-week Phlebotomy Program is awarding full scholarships for students who are accepted into the October program. Application deadline is Wednesday, September 6.
This week’s case study reviews the case of a 58-year-old man who received an above-the-knee amputation as treatment for a growing, painful right thigh mass. Can you make the diagnosis?
According to the Centers for Disease Control and Prevention, more than 20,000 people each year in the United States are diagnosed with myeloma, which is a cancer of the plasma cells. In this month’s “Hot Topic,” Dragan Jevremovic, M.D., Ph.D., reviews the diagnostic criteria for multiple myeloma and discusses the laboratory tests, including the use of next-generation sequencing, that can be used to help diagnose and manage patients with this disease.
Microcalcifications of the breast are detected through routine mammography. When identified, it’s necessary to ensure that these are not something more serious, such as colloid carcinoma or atypical ductal hyperplasia. In some cases, biopsy specimens demonstrate mucocele-like lesions of the breast. In this presentation, Daniel Visscher, M.D., discusses the Mayo Clinic experience in identifying these lesions and the associated risk of cancer.
The laboratory contributes to the health care system’s success through effective integration of testing from the community. The outreach program must have the proper focus, structure, and resources, and it must continually improve. Learn how to leverage your laboratory’s true value from industry experts.
This week’s case study reviews the request for antibody identification in a 28-year-old African-American female with previously negative antibody screens. Can you make the diagnosis?
Whole-exome sequencing offers a new level of genetic testing, but the test results require significant time and expertise to interpret. The results can frequently be difficult to communicate, both for technical reasons and because of the impact on the patient and family.